PANEL DISCUSSION: Leveraging Different Innate Cell Types for Therapeutic Efficacy in Oncology & Beyond

Time: 3:00 pm
day: Conference Day Two


With significant work taking place to understand the potential of novel innate cell types such as macrophages, neutrophils and iNKT cells for treatment applications in Oncology, attention also turns to the therapeutic application of innate cells for other important diseases such as inflammatory, autoimmune and fibrosis indications.

This panel discussion will cover:

  • Understanding the key therapeutic settings and requirements for innate cell applications in oncology and beyond
  • Discussing screening procedures to streamline dosing schedules in oncology
  • Building effective methods for patient stratification in non-oncology indications
  • Comparing combined modality strategies in oncology and non-oncology indications
  • Understanding the need for robust clinical endpoints to inform drug development outside of S9 for mon-oncology indications